Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
18 July 2019Website:
http://www.phreesia.comNext earnings report:
09 December 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 15 Nov 2024 23:27:32 GMTDividend
Analysts recommendations
Institutional Ownership
PHR Latest News
Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024.
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health EHR Expertise for its integration of the Phreesia platform.
Phreesia (PHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Phreesia, Inc. (NYSE:PHR ) Q2 2025 Earnings Conference Call September 4, 2024 5:00 PM ET Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Chief Executive Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Scott Schoenhaus - KeyBanc Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Glen Santangelo - Jefferies Stephanie Davis - Barclays Joe Vruwink - Baird John Ransom - Raymond James Richard Close - Canaccord Security Daniel Grosslight - Citi Sean Dodge - RBC Capital Markets Jeff Garro - Stephens Matthew Shea - Needham & Company Jack Wallace - Guggenheim Aaron Kimson - Citizens JMP Operator Good evening, ladies and gentlemen, and welcome to the Phreesia Second Quarter Fiscal 2025 Earnings Conference Call. At this time all participants are in a listen-only mode.
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Phreesia (PHR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.68 per share a year ago.
Get a deeper insight into the potential performance of Phreesia (PHR) for the quarter ended July 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.
What type of business is Phreesia?
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
What sector is Phreesia in?
Phreesia is in the Healthcare sector
What industry is Phreesia in?
Phreesia is in the Health Information Services industry
What country is Phreesia from?
Phreesia is headquartered in United States
When did Phreesia go public?
Phreesia initial public offering (IPO) was on 18 July 2019
What is Phreesia website?
https://www.phreesia.com
Is Phreesia in the S&P 500?
No, Phreesia is not included in the S&P 500 index
Is Phreesia in the NASDAQ 100?
No, Phreesia is not included in the NASDAQ 100 index
Is Phreesia in the Dow Jones?
No, Phreesia is not included in the Dow Jones index
When was Phreesia the previous earnings report?
No data
When does Phreesia earnings report?
The next expected earnings date for Phreesia is 09 December 2024